vTv Therapeutics' stock doubles after raising $51 million from health care investors including JDRF
After nearly getting delisted from Nasdaq, High Point's vTv Therapeutics has raised $51 million in a private placement to continue testing a promising diabetes drug. Investors include a big name in Type 1 Diabetes research, JDRF. Here's how vTv will use the funding. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 29, 2024 Category: Pharmaceuticals Authors: Lillian Johnson Source Type: news
Network analysis of depression, cognitive functions, and suicidal ideation in patients with diabetes: an epidemiological study in Iran - Daneshmand M, Kashefizadeh M, Soleimani M, Mirzaei S, Tayim N.
AIMS: The main aim of this study was to assess the prevalence of suicidal ideation and previous suicide attempts among Iranian patients diagnosed with Type-1 diabetes (T1D) and Type-2 diabetes (T2D). Additionally, the study sought to estimate the network s... (Source: SafetyLit)
Source: SafetyLit - February 19, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Revolutionary treatment for type 1 diabetes could see cells that act like the pancreas transplanted into patients' arms
New technology, developed at the University of California, San Francisco and Duke University, could free patients from the need to constantly manage their type 1 diabetes. (Source: the Mail online | Health)
Source: the Mail online | Health - February 17, 2024 Category: Consumer Health News Source Type: news
Pancreas Volume Predicts Progression to Stage 3 Type 1 Diabetes
THURSDAY, Feb. 15, 2024 -- Measures of pancreas volume and metabolism can predict progression to stage 3 type 1 diabetes, according to a study published online Dec. 27 in Diabetes Care.
John Virostko, Ph.D., from the University of Texas at Austin,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 15, 2024 Category: Pharmaceuticals Source Type: news
Protein Before Exercise Curbs Hypoglycemia Protein Before Exercise Curbs Hypoglycemia
In adolescents with type 1 diabetes, protein consumption before exercise shortened the duration of hypoglycemic episodes during physical activity but not after it.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 1, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply
(MedPage Today) -- Type 1 diabetes patients are upset over the looming discontinuation of Novo Nordisk's long-acting insulin detemir (Levemir). (USA Today)
Mid-life women with greater exposure to toxic metals like arsenic, cadmium, and mercury... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 30, 2024 Category: Endocrinology Source Type: news
Substance Abuse Ups DKA Readmission Risk in Type 1 Diabetes Substance Abuse Ups DKA Readmission Risk in Type 1 Diabetes
Patients with multiple hospital admissions for DKA had greater rates of substance use disorder with cannabis, tobacco, and psychoactive substances as well as higher incarceration rates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 26, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
Theresa May horrified by type 1 diabetes disordered eating
Better awareness and more NHS support are needed, the former prime minister says. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 23, 2024 Category: Consumer Health News Source Type: news
Theresa May's type 1 diabetes go-to was Jelly Babies
The former prime minister tells BBC News sweets helped her out in some sticky situations in meetings. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 23, 2024 Category: Consumer Health News Source Type: news
Mayo Clinic doctor who has made it his life mission to CURE diabetes - after three of his children were diagnosed with condition that will strike 1.5BILLION people by 2050
Dr Quinn Peterson, director of the Islet Engineering and Replacement Laboratory at the Mayo Clinic, is inspired to eventually cure type 1 diabetes, which three of his children have. (Source: the Mail online | Health)
Source: the Mail online | Health - January 20, 2024 Category: Consumer Health News Source Type: news
Automatic Hybrid Insulin Delivery Systems Help Manage T1D Automatic Hybrid Insulin Delivery Systems Help Manage T1D
A prospective evaluation by 16 diabetes specialists in Spain suggests that advanced hybrid closed-loop systems improve glycemic control in patients with type 1 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win
(MedPage Today) -- Vertex Pharmaceuticals put its phase I/II study of the investigational type 1 diabetes treatment VX-880 on a protocol-specified pause following two patient deaths that the company said were unrelated to the study drug.
Merck... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 9, 2024 Category: Endocrinology Source Type: news
Vertex pauses diabetes cell therapy study following two patient deaths
Vertex has pressed pause on its Phase 1/2 study of its insulin-producing cell therapy for patients with type 1 diabetes following two patient deaths that the company said were unrelated to the drug. This is the second time Vertex ’s progress on its diabetes drug has been paused. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 8, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
Maternal Type 1 Diabetes an Outsized Red Flag for Child Heart Defect Risk
(MedPage Today) -- Maternal type 1 diabetes (T1D) emerged as the larger contributor to the child's risk of congenital heart defect (CHD) when considering maternal diabetes and weight status together, a Finnish population-based cohort study found... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 5, 2024 Category: Cardiology Source Type: news
Maternal T1D, Overweight/Obesity Linked to Heart Defects in Offspring
FRIDAY, Jan. 5, 2024 -- Maternal type 1 diabetes and overweight and obesity are associated with an increased risk for congenital heart defects (CHDs) among offspring, according to a study published online Jan. 5 in JAMA Network Open.
Riitta... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 5, 2024 Category: Pharmaceuticals Source Type: news
